Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Cutan Pathol. 2012 Jan;39(1):17-20. doi: 10.1111/j.1600-0560.2011.01848.x.

The melanoma 'epidemic': lessons from prostate cancer.

Author information

  • Department of Pathology and Dermatology, Yale University School of Medicine, New Haven, CT 06510-3206, USA. earl.glusac@yale.edu

Abstract

The rise in malignant melanoma incidence has been termed "epidemic". Closer scrutiny of epidemiologic data suggests overdiagnosis as the true cause of the dramatic rise in melanoma incidence. In epidemiologic terms, "overdiagnosis" describes lesions that are histologically malignant but biologically benign. Overdiagnosis is not unique to melanoma screening but is prevalent in screening for cancers of other organs, including the thyroid and prostate glands.

Copyright © 2011 John Wiley & Sons A/S.

PMID:
22211331
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk